BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Deals

  SillaJen Grabs Jennerex, Inc. for $150 Million

  November 26, 2013

   · 

  7 min read
• Pharm Country

  Elite Pharmaceuticals, Inc. Announces Conversion Of Treppel Bridge Loan To Convertible Note

  November 26, 2013

   · 

  1 min read
• Business

  Merrimack Pharmaceuticals Inc. And Actavis Announce Nanotechnology Collaboration

  November 26, 2013

   · 

  1 min read
• Genetown

  Curis, Inc. To Present At Upcoming Investor Conferences

  November 26, 2013

   · 

  1 min read
• Stryker Orthopaedics R&D Executive To Speak At Clinical Research Conference On December 4, 2013

  November 26, 2013

   · 

  3 min read
• Gentium S.p.A. Release: Data From Non HSCT VOD Patients Treated With Defibrotide And A Treatment IND Update To Be Presented At The American Society of Hematology 2013 Annual Meeting

  November 26, 2013

   · 

  1 min read
• Pharm Country

  Immune Pharmaceuticals, Inc.'s Common Stock Approved For Trading On NASDAQ OMX First North Premier

  November 26, 2013

   · 

  4 min read
• Pharm Country

  Immune Pharmaceuticals, Inc.’ Common Stock Approved for Trading on NASDAQ OMX First North Premier

  November 26, 2013

   · 

  1 min read
• BioMidwest

  Athersys, Inc. To Present At 25th Annual Piper Jaffray Healthcare Conference

  November 26, 2013

   · 

  1 min read
• Drug Development

  Isis Pharmaceuticals, Inc. Initiates Phase 1 Study Of ISIS-GSK3 Rx And Earns $3 Million Milestone Payment From GlaxoSmithKline

  November 26, 2013

   · 

  3 min read